Research & Development World

  • Home Page
  • Topics
    • Aerospace
    • Archeology
    • Automotive
    • Biotech
    • Chemistry
    • COVID-19
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Market Pulse
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
      • Software
    • Semiconductors
  • 2021 R&D 100 Award Winners
    • R&D 100 Awards
    • 2020 Winners
    • Winner Archive
  • Resources
    • Digital Issues
    • Podcasts
    • Subscribe
  • Global Funding Forecast
  • Webinars

NICE Plays Key Role in European Project to Help Give Better Care to Blood Cancer Patients

By NICE | April 3, 2017

NICE will join over 50 organisations across Europe in a five-year project called HARMONY.

Using big data to increase understanding of blood cancers, the project aims to speed up the development and patient access to innovative medicines for this disease area.

Big data refers to large or complex data sets that can be analysed computationally to reveal patterns.

The HARMONY project will create a European wide big data platform that will focus on clinical outcomes that matter most to patients, clinicians and organisations such as NICE. Data that will be captured includes anonymised patient data, results from clinical trials, registries, hospitals and academic or treatment centres.

This data can be shared across relevant private, academic and public sector organisations to help increase understanding of blood cancers.

Professor Carole Longson, director of the centre for health technology evaluation at NICE, said: “Blood cancers are a collection of complex diseases caused by a range of genetic mutations. Improving patients’ outcomes can be challenging but a greater understanding of the molecular causes of this disease area offers opportunities for more focused and successful treatment options, such as personalised medicines.

“NICE is delighted to be contributing to HARMONY. This project will help ensure appropriate data is generated to improve understanding of these diseases and help facilitate the development and subsequent assessment of new treatments.”

Eric Low, chief executive at Myeloma UK, said: “Although there have been many significant advances in the treatment of haematological malignancies over the last decade, it is still a very challenging and varied group of cancers to diagnose and treat.

“Working at a pan-European level and harnessing the power of big data should provide the evidence and knowledge needed to optimise current treatment approaches by making sure the right patients get the right treatment at the right time.”

HARMONY is a project that falls under the Innovative Medicines Initiative (IMI) Big Data for Better Outcomes Programme. Its €40 million budget is distributed among 51 partners from the private and public sector, as well as academic institutions, including NICE.

Related Articles Read More >

PerkinElmer participating at Bio-IT World Conference & Expo
Nalu Medical’s mIPG is focus of Episode 7 of R&D 100 – The Podcast
R&D 100 winner of the day: Portable EnGineered Analytic Sensor with aUtomated Sampling (PEGASUS)
UCLA bioengineers develop new class of human-powered bioelectronics
2021 R&D Global Funding Forecast

Need R&D World news in a minute?

We Deliver!
R&D World Enewsletters get you caught up on all the mission critical news you need in research and development. Sign up today.
Enews Signup

R&D World Digital Issues

February 2020 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R& magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • 2021 Global Funding Forecast

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • Home Page
  • Topics
    • Aerospace
    • Archeology
    • Automotive
    • Biotech
    • Chemistry
    • COVID-19
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Market Pulse
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
      • Software
    • Semiconductors
  • 2021 R&D 100 Award Winners
    • R&D 100 Awards
    • 2020 Winners
    • Winner Archive
  • Resources
    • Digital Issues
    • Podcasts
    • Subscribe
  • Global Funding Forecast
  • Webinars